Question 1

What are the specific goals of this trial and how might they benefit my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease clinical trial (NCT06257706). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the treatment with vedolizumab work, and what should I expect?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease clinical trial (NCT06257706). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease clinical trial (NCT06257706). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease clinical trial (NCT06257706). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease clinical trial (NCT06257706). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease clinical trial (NCT06257706). Contact the study team or your healthcare provider for specific answers.

What this study is about